NANOVIRICIDES, INC. 4
4 · NANOVIRICIDES, INC. · Filed Sep 24, 2015
Insider Transaction Report
Form 4
Diwan Anil
DirectorPresident10% Owner
Transactions
- Tax Payment
Common Stock, par value $0.001 per share
2015-09-22$1.30/sh−76,944$100,027→ 2,005,366 total - Exercise/Conversion
Common Stock, par value $0.001 per share
2015-09-22$0.35/sh+208,771$73,070→ 2,082,310 total - Exercise/Conversion
Common Stock Options
2015-09-22−285,715→ 0 totalExercise: $0.35From: 2005-06-30Exp: 2015-09-26→ Common Stock (285,715 underlying)
Footnotes (2)
- [F1]Does not include 571,429 shares of Series A Convertible Preferred Stock (the "Series A Preferred Stock") which votes at the rate of nine shares of Common Stock per each share of Series A and is convertible into three and one half shares of Common Stock upon a change in control of the Company or upon achieving certain trading prices of the Common Stock. Also does not include 16,531,429 shares owned by TheraCour Pharma, Inc. (calculating the Series A, over which Dr. Diwan holds voting and dispositive power.
- [F2]Reflects 76,944 shares withheld by the Issuer at the market price of $1.30 per share, less an exercise price of $0.35 per share, to fund the cashless exercise of 208,771 options.